JPMorgan's list of highest conviction names includes GLP-1, weight loss stocks and potential beneficiaries of growing demand for data centers.
JPMorgan believes that a handful of stocks have what it takes to outperform their peers. A months-long rally for the equity market pushed the Dow Jones Industrial Average above 40,000 last week for the first time in history. But despite this upward move, good investment opportunities remain in the market, according to JPMorgan.
Analyst Harlan Sur noted that one of his top picks includes semiconductor manufacturer Broadcom , which has rallied 25% in 2024. As catalysts, he highlighted Broadcom's strong exposure to AI and a diversified revenue mix, alongside strong market share, profitability, free cash flow and capital return. In the report, the bank also highlighted data centers as an area that investors should watch.
Stock Markets Eli Lilly And Co Broadcom Inc GS Acquisition Holdings Corp Delta Air Lines Inc Carvana Co JPMORGAN DRN Business News
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
JPMorgan says there's a new GLP-1 drug player and its shares can rally 80%Structure Therapeutics could one day boast a competitive obesity product an go up against Eli Lilly and the like, according to JPMorgan.
Read more »
Denmark to Restrict Ozempic, Other GLP-1 Drugs, to Treat Type 2 DiabetesDenmark will start putting patients suffering from type 2 diabetes on cheaper drugs before prescribing so-called GLP-1 drugs such as Novo Nordisk's Ozempic, the Danish...
Read more »
Mom Loses 65 Lbs With GLP-1, Counting Macros, Strength TrainingStephanie Thurrott is a writer who covers mental health, personal growth, wellness, family, food and personal finance, and dabbles in just about any other topic that grabs her attention. When she's not writing, look for her out walking her dog or riding her bike in Pennsylvania's Lehigh Valley.
Read more »
No, GLP-1 Supplements *Are Not* the Same as Prescription Drugs Like OzempicLearn how GLP-1 weight loss medications like Wegovy work in the body and whether over-the-counter GLP-1 supplements are as effective.
Read more »
GLP-1 Receptor Agonists Before Endoscopy: AGA Issues Rapid Clinical Practice UpdateThe update included background on the relationship between GLP-1 receptor agonists and endoscopic procedures, followed by clinical strategies for patients taking these medications.
Read more »
Survey Suggests One in Eight US Adults May Have Used a GLP-1 DrugA KFF poll also suggests half of the respondents who had tried these weight loss meds no longer took them, with many reporting difficulties paying for these drugs.
Read more »